OQS
BCAB icon

Occudo Quantitative Strategies’s BioAtla BCAB Stock Holding History

Occudo Quantitative Strategies’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-434
Closed -$58.2K – 1021
2023
Q1 		$58.2K Buy
+434
New +$78.2K 0.01% 845
2022
Q4 		– Sell
-398
Closed -$153K – 973
2022
Q3 		$153K Sell
398
-498
-56% -$163K 0.01% 996
2022
Q2 		$128K Sell
896
-1,413
-61% -$225K 0.01% 981
2022
Q1 		$577K Buy
+2,309
New +$966K 0.05% 586

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's BCAB Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 434 shares — an estimated $58.2K sold.

Occudo Quantitative Strategies first reported a position in BCAB in Q1 2022 and held it in 4 quarters. The position peaked at $577K in Q1 2022. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 434 BioAtla shares in Q2 2023, an estimated $58.2K.
  • Occudo Quantitative Strategies first reported a position in BioAtla in Q1 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's BioAtla position peaked at $577K in Q1 2022.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.